secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2026-08-21T20:34:49+00:00
Accession:  0001437749-26-028744
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia receives Nasdaq deficiency notice for bid price below $1.00
---------------------------------------------------------------------

- Received Nasdaq notice on Aug 19, 2026; bid price below $1.00 for 30 consecutive business days.
- Granted 180 days until Feb 16, 2027 to regain compliance via $1.00+ closing bid for 10 straight days.
- No immediate impact on listing; company may pursue reverse stock split if needed.
- Failure to cure could lead to delisting, with eligibility for additional 180-day period or hearing appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774926028744/0001437749-26-028744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774926028744/bcda20260819_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-028744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer